Dr. Majid Taati Moghadam is a dedicated Medical Microbiologist and Antimicrobial Resistance Researcher based in Rasht, Iran. He specializes in microbial pathogenesis, antibiotic resistance mechanisms, bacteriophage therapy, and the connection between microbiota and neurodegenerative disorders. His multidisciplinary expertise extends across clinical microbiology, infectious disease prevention, and translational therapeutics, making him a leading figure in Iran’s microbiological research community.
Professional Profile
Google Scholar
ORCID
Scopus
Education
Dr. Majid Taati Moghadam earned his Ph.D. in Medical Bacteriology from Iran University of Medical Sciences (2017–2022), focusing on oral microbiota shifts in Alzheimer’s patients. He previously completed his Master’s degree in Medical Microbiology at Kerman University of Medical Sciences (2012–2015), where he explored resistance gene prevalence in Klebsiella pneumoniae. His academic journey began with a Bachelor’s degree in Microbiology from Islamic Azad University, Lahijan Branch (2007–2012).
Experience
Dr. Majid Taati Moghadam has led and collaborated on over a dozen cutting-edge research projects, ranging from beta-lactamase resistance genes to antimicrobial herbal wound dressings. His roles have spanned principal investigator to main collaborator in studies involving nosocomial pathogens, molecular diagnostics, and phage therapeutics. He also authored a Persian-language textbook titled Essential Medical Microbiology and has actively participated in numerous scientific congresses in Iran.
Research Interests
His core research interests include antimicrobial resistance in Gram-negative bacteria, molecular epidemiology, phage therapy, engineered phage enzymes, biofilm disruption, and the microbiota’s impact on neurological and mental health disorders. He is particularly recognized for his investigations on colistin-resistant superbugs and bacteriophage applications in clinical infections.
Awards
Dr. Majid Taati Moghadam pioneering work in antimicrobial resistance and translational microbiology has earned him national recognition and multiple nominations for academic excellence. He is a strong candidate for the “Best Researcher Award” at the International Forensic Scientist Awards, given his substantial scholarly contributions, high-impact research, and policy-relevant insights into infectious disease control.
Publications
-
Global prevalence and distribution of vancomycin resistant, vancomycin intermediate and heterogeneously vancomycin intermediate Staphylococcus aureus clinical isolates: a systematic review and meta-analysis
Authors: A Shariati, M Dadashi, MT Moghadam, A van Belkum, S Yaslianifard, …
Year: 2020
Citations: 316
-
Bacteriophage therapy against Pseudomonas aeruginosa biofilms: a review
Authors: Z Chegini, A Khoshbayan, M Taati Moghadam, I Farahani, P Jazireian, …
Year: 2020
Citations: 311
-
How phages overcome the challenges of drug resistant bacteria in clinical infections
Authors: M Taati Moghadam, N Amirmozafari, A Shariati, M Hallajzadeh, …
Year: 2020
Citations: 173
-
Bacteriophages, a new therapeutic solution for inhibiting multidrug-resistant bacteria causing wound infection: lesson from animal models and clinical trials
Authors: M Taati Moghadam, A Khoshbayan, Z Chegini, I Farahani, A Shariati
Year: 2020
Citations: 125
-
COVID-19 (Coronavirus disease 2019): a new coronavirus disease
Authors: A Sadeghi Dousari, M Taati Moghadam, N Satarzadeh
Year: 2020
Citations: 108
-
Evaluation of Nano-curcumin effects on expression levels of virulence genes and biofilm production of multidrug-resistant Pseudomonas aeruginosa isolated from clinical samples
Authors: A Shariati, E Asadian, F Fallah, T Azimi, A Hashemi, J Yasbolaghi Sharahi, …
Year: 2019
Citations: 108
-
Bacteriophage as a novel therapeutic weapon for killing colistin-resistant multi-drug-resistant and extensively drug-resistant gram-negative bacteria
Authors: SM Mousavi, S Babakhani, L Moradi, S Karami, M Shahbandeh, …
Year: 2021
Citations: 58
-
The effects of probiotics on reducing the colorectal cancer surgery complications: a periodic review during 2007–2017
Authors: A Darbandi, M Mirshekar, A Shariati, MT Moghadam, V Lohrasbi, …
Year: 2020
Citations: 50
-
Ramadan fasting during the COVID-19 pandemic; observance of health, nutrition and exercise criteria for improving the immune system
Authors: MT Moghadam, B Taati, SM Paydar Ardakani, K Suzuki
Year: 2021
Citations: 48
-
The Challenge of Global Emergence of Novel Colistin-Resistant Escherichia coli ST131
Authors: M Taati Moghadam, M Mirzaei, M Fazel Tehrani Moghaddam, …
Year: 2021
Citations: 44
Conclusion
Dr. Majid Taati Moghaddam Ziabari exemplifies innovation and academic rigor in the fight against antimicrobial resistance. Through a prolific publication record, cross-disciplinary research, and dedication to molecular microbiology, he has positioned himself as a thought leader in clinical microbiology and public health. His nomination for the “Best Researcher Award” recognizes not only his scholarly excellence but also his commitment to advancing biomedical solutions for global health challenges.
